CompletedPhase 2NCT02636868
The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
Studying Infant acute respiratory distress syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Windtree Therapeutics
- Principal Investigator
- Steven Simonson, MDWindtree Therapeutics
- Intervention
- Lucinactant delivered via investigational delivery device(drug)
- Enrollment
- 221 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2019
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Univ. of Arkansas Medical Center, Little Rock, Arkansas, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Sharp Mary Birch Hospital for Women and Newborns, San Diego, California, United States
- Christiana Care Health System, Newark, Delaware, United States
- University of Miami Holtz Children's Hospital, Miami, Florida, United States
- University of Michigan Health System, Ann Arbor, Michigan, United States
- University of Mississippi Medical Center, Jackson, Mississippi, United States
- University of Nebraska Medical Center, Omaha, Nebraska, United States
- Albany Medical Center, Albany, New York, United States
- Morgan Stanley Childrens Hospital of New York Presbyterian (CHONY), New York, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Brody School of Medicine at ECU, Greenville, North Carolina, United States
- New Hanover Regional Medical Center, Wilmington, North Carolina, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02636868 on ClinicalTrials.govOther trials for Infant acute respiratory distress syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07344714Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU SettingMayo Clinic
- RECRUITINGNCT07216053Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm NeonatesHackensack Meridian Health
- RECRUITINGNANCT03736707High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority TrialDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGPHASE3NCT06776783Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress SyndromeAerogen Pharma Limited
- ENROLLING BY INVITATIONNANCT07235345To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted VentilationXu Falin
- RECRUITINGNANCT06757543A Stepped Wedge Cluster Randomised Trial of Video Versus Direct Laryngoscopy for Intubation of Newborn InfantsUniversity College Dublin
- RECRUITINGNCT06758492A Prospective Observational Study of Video Laryngoscopy Versus Direct Laryngoscopy for Insertion of a Thin Endotracheal Catheter for Surfactant Administration in Newborn InfantsUniversity College Dublin
- RECRUITINGNANCT06622902Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.Rambam Health Care Campus
See all trials for Infant acute respiratory distress syndrome →